Equities

Sera Prognostics Inc

  • Add to watchlist
  • Add to portfolio
  • Add an alert
SERA:NMQ

Sera Prognostics Inc

Actions
Health CareMedical Equipment and Services
  • Price (USD)2.11
  • Today's Change-0.12 / -5.38%
  • Shares traded33.49k
  • 1 Year change-49.03%
  • Beta1.0233
Data delayed at least 15 minutes, as of Mar 03 2026 21:00 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Sera Prognostics, Inc. is a women's health diagnostic company utilizing its proprietary proteomics and bioinformatics platform, and significant data resources to enhance maternal and neonatal health by discovering, developing, and commercializing blood-based biomarker tests, and predictive analytic products and services. It has built a proteomics and bioinformatics platform to characterize the biology of pregnancy and to discover and validate key protein biomarkers found in blood that are accurate predictors of dynamic changes that occur during pregnancy. Its commercial product, the PreTRM test, is a validated, commercially available blood-based biomarker test to predict the risk of a premature delivery, also known as preterm birth. The PreTRM test is a non-invasive blood test given to a pregnant woman, carrying a single fetus, during weeks 18 through 20 of gestation that provides a prediction of the expectant mother’s risk of delivering spontaneously before 37 weeks’ gestation.

  • Revenue in USD (TTM)95.00k
  • Net income in USD-32.63m
  • Incorporated2008
  • Employees63.00
  • Location
    Sera Prognostics Inc2749 E. Parleys Way, Suite 200SALT LAKE CITY 84109United StatesUSA
  • Phone+1 (801) 505-0278
  • Fax+1 (302) 655-5049
  • Websitehttps://www.sera.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Concorde International Group Ltd10.49m-83.64m47.31m134.00--18.41--4.51------0.0952------78,288.59--------34.46---797.12-----465.660.7356---1.55---8,805.97------
Bitcoin Depot Inc635.64m9.16m49.87m126.00--10.741.160.0785-2.20-2.20131.310.44335.98--672.285,044,786.0033.26--62.54--19.43--5.57----3.770.7692---16.73--55.23------
Birchtech Corp19.09m-4.05m57.58m12.00------3.02-0.211-0.2110.9873-0.05891.7514.236.861,590,651.00-37.14-25.70-119.86-50.0048.3935.17-21.20-20.780.5002-------1.248.80-290.57------
Team Inc884.95m-53.22m64.17m5.40k------0.0725-11.85-11.85197.237.111.6415.994.57163,880.20-9.78-20.57-14.18-30.5926.0725.43-5.95-16.221.690.34150.9045---1.20-6.0349.47---20.08--
BGSF Inc178.05m-9.64m66.97m405.00--1.32--0.3762-0.8747-1.0216.194.531.48--5.82439,617.30-8.010.7757-10.771.0133.9634.22-5.420.4575---0.52560.00396.94-12.994.4067.35---5.96--
ATIF Holdings Ltd1.20m-4.60m68.58m6.00--0.9038--57.15-5.77-5.771.467.360.1784--2.53200,000.00-68.36-30.16-78.68-46.73-----383.17-238.82---0.2410.0252--93.5513.22-44.07------
OneSolution Technology Inc647.54k-1.14m69.78m3.00------107.76-0.3098-0.30980.0323-0.012916.65--18.02215,846.70-2,932.19------12.76---176.15----------9.42--229.23------
Balance Labs Inc0.00-3.86m72.62m-----------0.1758-0.17580.00-0.38640.00-------4,728.35-68.90-----------114.14---0.1217---------38.43------
Mastech Digital Inc191.37m609.00k73.34m1.53k125.830.821233.990.38330.04980.049816.127.631.71--6.62--0.54543.260.67044.0627.7226.740.31821.69---------3.81-0.2829-82.10-42.70----
Nordicus Partners Corp0.00-4.55m75.55m15.00--1.17-----0.2558-0.25580.003.430.00-------6.74-30.62-6.83-31.20-------164,009.30---6.480.00--100.00---872.94---74.40--
Sera Prognostics Inc95.00k-32.63m81.44m63.00--0.9903--857.21-0.7696-0.76960.00222.130.001--2.041,507.94-34.87-39.90-46.79-48.53-62.1129.68-34,343.16-22,187.73----0.00004---74.8416.429.23--58.81--
Master Glazier's Karate InternationalInc722.00k-1.95m84.88m9.00--0.1947--117.57-47.94-47.9417.7435.950.24750.33978.2580,222.22-66.88---77.82--85.3290.24-270.22-99.572.13--0.00---49.020.3494-33.87---33.64--
Renewal Fuels Inc2.26m-3.23m92.66m10.00------41.02-0.086-0.09760.0588-0.09811.367.64--225,900.00-195.23-274.47----32.057.36-143.07-469.430.024-1.2612.78---56.8014.24-59,057.89--13.41--
Generation Essentials Group0.001.24m94.56m--22.960.1873----0.06490.06490.007.96----------------------------0.00--------------
DHI Group Inc127.83m-13.11m116.47m270.00--1.2279.390.9112-0.2882-0.28822.852.130.6241--6.38473,429.60-6.40-0.5401-8.98-0.768184.6686.64-10.26-0.8669--6.620.241---9.932.83-5,439.92---14.61--
Data as of Mar 03 2026. Currency figures normalised to Sera Prognostics Inc's reporting currency: US Dollar USD

Institutional shareholders

38.15%Per cent of shares held by top holders
HolderShares% Held
Baker Bros. Advisors LPas of 31 Dec 20255.50m14.61%
Whetstone Capital Advisors LLCas of 31 Dec 20253.46m9.20%
abrdn, Inc.as of 31 Dec 20252.28m6.06%
The Vanguard Group, Inc.as of 31 Dec 20251.06m2.81%
Citadel Advisors LLCas of 31 Dec 2025627.41k1.67%
CapFinancial Partners LLCas of 31 Dec 2025536.77k1.43%
Geode Capital Management LLCas of 31 Dec 2025334.64k0.89%
AWM Investment Co., Inc.as of 31 Dec 2025207.38k0.55%
BlackRock Fund Advisorsas of 31 Dec 2025181.37k0.48%
Vanguard Fiduciary Trust Co.as of 31 Dec 2025169.66k0.45%
More ▼
Data from 31 Dec 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.